DFDA

Lifestyle Modifications (Diet & Exercise)

Treatment for Polycystic Ovary Syndrome

Typical Dosage: 30-60 minutes moderate exercise most days; balanced diet

Effectiveness
85%
Safety Score
95%
Clinical Trials
3
Participants
1M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
30-60 minutes moderate exercise most days; balanced diet
Time to Effect
3-6 months
Treatment Duration
lifetime
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$800
Side Effect Mgmt:$0
Total Annual:$800
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
0
QALYs Gained
1.2
Outcome-Based Costs
Cost per Responder
$714
Cost per Remission
$2,500
Lifestyle Modifications (Diet & Exercise) Outcomes

for Polycystic Ovary Syndrome

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+70%
Remission Rate
+20%
Common Side Effects
Muscle soreness
+15%
Increased hunger
+10%

Sources:

frontiersin.org
monash.edu
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Lifestyle Modifications (Diet & Exercise) in Polycystic Ovary Syndrome

Comparison of Pregnancy Outcomes in Women with Polycystic Ovarian Syndrome with and Without Glucophage

NCT06713967NOT YET RECRUITINGNA
View Study
70 participants
INTERVENTIONAL
Started: Feb 2, 2025
Completed Clinical Trials
2 completed trials for Lifestyle Modifications (Diet & Exercise) in Polycystic Ovary Syndrome

Short-term Structured Exercise Training Program Plus Diet Intervention in Patients With Polycystic Ovary Syndrome (PCOS)

NCT01004068COMPLETEDPHASE4
View Study
96 participants
INTERVENTIONAL
Catanzaro, Italy
Started: Feb 1, 2008

The Impact of a Pharmaceutical Care Model on Improving Polycystic Ovary Syndrome

NCT04416620COMPLETEDNA
View Study
118 participants
INTERVENTIONAL
Amman, Jordan +3 more
Started: Feb 1, 2017